Literature DB >> 6294226

Neuraminidase-sensitive erythrocyte receptor for enterovirus type 70.

E T Utagawa, K Miyamura, A Mukoyama, R Kono.   

Abstract

Enterovirus type 70 (EV70) agglutinated human 'O' erythrocytes at 4 degrees C as well as 22 degrees C, but visible agglutination was lost when warmed at 37 degrees C although the virus remained attached to the surface of the erythrocyte. The receptor sites for the virus were neuraminidase-sensitive. A direct involvement of sialic acid on the cell surface in virus-cell interaction was confirmed by the fact that the presence of fetuin or free N-acetylneuraminic acid inhibited the haemagglutinating activity of EV70. Similar numbers of virus particles were required for 1 haemagglutinating unit (HAU) of EV70 and 1 HAU of mengovirus, whereas 2.6-fold or more of virus particles of echovirus type 7 and type 11 gave the same activity. On the other hand, the number of receptor sites on the cell surface for EV70 was found to be sevenfold more than for mengovirus. Therefore, the erythrocyte receptor for EV70 is different from that for common enteroviruses and similar, though not identical, to the cardiovirus receptor. However, serological tests such as neutralization, complement fixation or haemagglutination inhibition did not reveal any common antigen between EV70 and cardiovirus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294226     DOI: 10.1099/0022-1317-63-1-141

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features.

Authors:  Soile Blomqvist; Carita Savolainen; Laura Råman; Merja Roivainen; Tapani Hovi
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).

Authors:  T M Karnauchow; D L Tolson; B A Harrison; E Altman; D M Lublin; K Dimock
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Sialic acid functions in enterovirus 70 binding and infection.

Authors:  David A Alexander; Kenneth Dimock
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses.

Authors:  R H Yolken; R Willoughby; S B Wee; R Miskuff; S Vonderfecht
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  Evolution of enterovirus 70 in nature: all isolates were recently derived from a common ancestor.

Authors:  K Miyamura; M Tanimura; N Takeda; R Kono; S Yamazaki
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.

Authors:  M Reza Nokhbeh; Samir Hazra; David A Alexander; Ahmar Khan; Morgan McAllister; Erik J Suuronen; May Griffith; Kenneth Dimock
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane.

Authors:  Glòria Sánchez; Lluís Aragonès; M Isabel Costafreda; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.

Authors:  Alain Haddad; M Reza Nokhbeh; David A Alexander; Sandra J Dawe; Christine Grisé; Naveed Gulzar; Kenneth Dimock
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity.

Authors:  Melissa Stewart Kim; Vincent R Racaniello
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

10.  Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.

Authors:  T M Karnauchow; S Dawe; D M Lublin; K Dimock
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.